PLXP Annual FCF
-$32.12 M
-$19.77 M-160.17%
31 December 2021
Summary:
As of February 5, 2025, PLXP annual free cash flow is -$32.12 million, with the most recent change of -$19.77 million (-160.17%) on December 31, 2021. During the last 3 years, it has fallen by -$21.96 million (-216.31%).PLXP Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PLXP Quarterly FCF
-$10.98 M
+$7.12 M+39.32%
30 September 2022
Summary:
As of February 5, 2025, PLXP quarterly free cash flow is -$10.98 million, with the most recent change of +$7.12 million (+39.32%) on September 30, 2022. Over the past year, it has dropped by -$1.98 million (-22.05%).PLXP Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PLXP TTM FCF
-$59.34 M
-$1.98 M-3.46%
30 September 2022
Summary:
As of February 5, 2025, PLXP TTM free cash flow is -$59.34 million, with the most recent change of -$1.98 million (-3.46%) on September 30, 2022. Over the past year, it has dropped by -$38.06 million (-178.88%).PLXP TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PLXP Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -160.2% | -22.1% | -178.9% |
| 3 y3 years | -216.3% | -233.9% | -359.9% |
| 5 y5 years | -132.0% | -514.6% | -359.9% |
PLXP Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +1980.5% | -378.7% | -5680.8% |
PLx Pharma Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$10.98 M(-39.3%) | -$59.34 M(+3.5%) |
| June 2022 | - | -$18.10 M(+7.1%) | -$57.35 M(+28.2%) |
| Mar 2022 | - | -$16.89 M(+26.4%) | -$44.73 M(+39.3%) |
| Dec 2021 | -$32.12 M(+160.2%) | -$13.36 M(+48.5%) | -$32.12 M(+51.0%) |
| Sept 2021 | - | -$9.00 M(+64.3%) | -$21.28 M(+37.2%) |
| June 2021 | - | -$5.48 M(+27.9%) | -$15.50 M(+20.7%) |
| Mar 2021 | - | -$4.28 M(+70.0%) | -$12.85 M(+4.1%) |
| Dec 2020 | -$12.35 M(-4.3%) | -$2.52 M(-21.9%) | -$12.34 M(-8.9%) |
| Sept 2020 | - | -$3.23 M(+14.2%) | -$13.56 M(-0.5%) |
| June 2020 | - | -$2.82 M(-25.2%) | -$13.62 M(+1.7%) |
| Mar 2020 | - | -$3.78 M(+1.2%) | -$13.40 M(+3.8%) |
| Dec 2019 | -$12.90 M(+27.1%) | -$3.73 M(+13.5%) | -$12.90 M(+12.6%) |
| Sept 2019 | - | -$3.29 M(+26.5%) | -$11.46 M(+19.9%) |
| June 2019 | - | -$2.60 M(-20.8%) | -$9.55 M(+1.1%) |
| Mar 2019 | - | -$3.28 M(+43.4%) | -$9.45 M(-6.9%) |
| Dec 2018 | -$10.15 M(-26.7%) | -$2.29 M(+64.8%) | -$10.15 M(-27.0%) |
| Sept 2018 | - | -$1.39 M(-44.4%) | -$13.90 M(-2.8%) |
| June 2018 | - | -$2.49 M(-37.4%) | -$14.30 M(-8.5%) |
| Mar 2018 | - | -$3.99 M(-33.9%) | -$15.63 M(+12.9%) |
| Dec 2017 | -$13.84 M | -$6.03 M(+237.7%) | -$13.84 M(+68.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | -$1.79 M(-53.2%) | -$8.21 M(+22.6%) |
| June 2017 | - | -$3.82 M(+73.6%) | -$6.70 M(-730.1%) |
| Mar 2017 | - | -$2.20 M(+446.4%) | $1.06 M(-158.7%) |
| Dec 2016 | -$1.81 M(-87.6%) | -$403.00 K(+47.7%) | -$1.81 M(-66.3%) |
| Sept 2016 | - | -$272.80 K(-106.9%) | -$5.38 M(-43.4%) |
| June 2016 | - | $3.94 M(-177.7%) | -$9.49 M(-42.9%) |
| Mar 2016 | - | -$5.08 M(+27.8%) | -$16.63 M(+13.9%) |
| Dec 2015 | -$14.59 M(+29.4%) | -$3.97 M(-9.5%) | -$14.59 M(+8.3%) |
| Sept 2015 | - | -$4.39 M(+37.6%) | -$13.47 M(+13.8%) |
| June 2015 | - | -$3.19 M(+4.9%) | -$11.84 M(-1.9%) |
| Mar 2015 | - | -$3.04 M(+6.6%) | -$12.07 M(+7.0%) |
| Dec 2014 | -$11.28 M(+413.9%) | -$2.85 M(+3.7%) | -$11.28 M(+21.5%) |
| Sept 2014 | - | -$2.75 M(-19.6%) | -$9.28 M(+25.9%) |
| June 2014 | - | -$3.42 M(+52.0%) | -$7.37 M(+76.2%) |
| Mar 2014 | - | -$2.25 M(+162.5%) | -$4.18 M(+90.7%) |
| Dec 2013 | -$2.19 M(+42.1%) | -$857.50 K(+1.7%) | -$2.19 M(+64.1%) |
| Sept 2013 | - | -$842.90 K(+263.2%) | -$1.34 M(+170.7%) |
| June 2013 | - | -$232.10 K(-11.3%) | -$493.90 K(+88.7%) |
| Mar 2013 | - | -$261.80 K | -$261.80 K |
| Dec 2012 | -$1.54 M | - | - |
FAQ
- What is PLx Pharma annual free cash flow?
- What is the all time high annual FCF for PLx Pharma?
- What is PLx Pharma annual FCF year-on-year change?
- What is PLx Pharma quarterly free cash flow?
- What is the all time high quarterly FCF for PLx Pharma?
- What is PLx Pharma quarterly FCF year-on-year change?
- What is PLx Pharma TTM free cash flow?
- What is the all time high TTM FCF for PLx Pharma?
- What is PLx Pharma TTM FCF year-on-year change?
What is PLx Pharma annual free cash flow?
The current annual FCF of PLXP is -$32.12 M
What is the all time high annual FCF for PLx Pharma?
PLx Pharma all-time high annual free cash flow is -$1.54 M
What is PLx Pharma annual FCF year-on-year change?
Over the past year, PLXP annual free cash flow has changed by -$19.77 M (-160.17%)
What is PLx Pharma quarterly free cash flow?
The current quarterly FCF of PLXP is -$10.98 M
What is the all time high quarterly FCF for PLx Pharma?
PLx Pharma all-time high quarterly free cash flow is $3.94 M
What is PLx Pharma quarterly FCF year-on-year change?
Over the past year, PLXP quarterly free cash flow has changed by -$1.98 M (-22.05%)
What is PLx Pharma TTM free cash flow?
The current TTM FCF of PLXP is -$59.34 M
What is the all time high TTM FCF for PLx Pharma?
PLx Pharma all-time high TTM free cash flow is $1.06 M
What is PLx Pharma TTM FCF year-on-year change?
Over the past year, PLXP TTM free cash flow has changed by -$38.06 M (-178.88%)